The combination of a director's $200K buy, a $5M open-market purchase by a major venture holder, and a $20.4M cash derivative conversion by another large investor on the same day represents an unusually strong insider conviction signal. The total cash deployment of ~2.6% of market cap is highly material. Monitor for a near-term catalyst such as a clinical trial readout, partnership, or financing event that may have prompted this coordinated buying.
Price Chart
Executive Summary
Director Paul J. Sekhri made a $200K open-market purchase of APMD at $16/share on August 3, 2026, alongside a large insider cluster involving major venture investors (Morningside, Alpha Wave) converting derivatives and making a $5M open-market buy. The cluster includes $20.4M in cash-converted derivative exercises and a $5M open-market purchase by Morningside, signaling strong insider conviction ahead of a potential catalyst.
Key Financial Metrics
Key Facts
- Director Paul J. Sekhri purchased 12,500 shares at $16.00 for $200K on August 3, 2026.
- Morningside Venture Investments purchased 312,500 shares at $16.00 for $5.0M on the same day.
- Alpha Wave Ventures converted derivatives into 1,512,480 shares at $13.50 for $20.4M in cash.
- Total open-market and cash-converted insider buying on August 3, 2026: ~$25.6M, representing ~2.6% of APMD's $1.0B market cap.
- The cluster includes non-cash derivative conversions and dispositions by insiders, but the cash purchases dominate the economic signal.
Financial Impact
~$25.6M in cash purchases and cash-converted derivative exercises on a single day, representing ~2.6% of market cap.
Risk Factors
- Insider buying may precede a dilutive financing that offsets the signal.
- The company is a clinical-stage biotech with no approved products; regulatory or trial failure risk is high.
- The $5M Morningside purchase is large but represents a small fraction of their total holdings; it may be a routine rebalancing.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001193125-26-330507 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 11w ago | Insider Cluster | $27.88 $27.81 | ▼ −0.25% | ▼ −0.85% | $18.95 (−32.03%) |
Aug 3, 2026 12w ago | Insider Buy | $25.71 $26.85 | ▲ +4.43% | ▲ +5.67% | $18.95 (−26.29%) |
Jul 31, 2026 12w ago | 424B4 | $25.00 $26.25 | ▲ +5.00% | ▲ +3.76% | $18.95 (−24.20%) |
Jul 31, 2026 12w ago | EFFECT | $25.00 $29.71 | ▲ +18.84% | ▲ +15.85% | $18.95 (−24.20%) |
Jul 30, 2026 12w ago | 3 | $25.00 $29.71 | ▲ +18.84% | ▲ +15.85% | $18.95 (−24.20%) |
Jul 27, 2026 13w ago | S-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers